Anticoagulation in continuous veno-venous haemofiltration.
The reasons for introduction of a heparin protocol are explained, with best practice principles of a protocol stated. The pharmacological properties of heparin are explained, and standardisation of monitoring procedures discussed. The responsibilities of the nurse in both laboratory and clinical monitoring of the effects of heparin are discussed. The use of an algorithm to alter heparin dosages against APPT results is justified.